Zoliflodacin
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Importance of the gonococcal MtrCDE efflux pump system in decreasing bacterial susceptibility to zoliflodacin: implications for future clinical treatment of gonorrhea.
Journal: mBio
Published: September 08, 2026
Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrBD429N in Neisseria gonorrhoeae.
Journal: Antimicrobial agents and chemotherapy
Published: August 19, 2026
In vitro activity of zoliflodacin against Neisseria gonorrhoeae collected in the United States from 2020 to 2022.
Journal: Antimicrobial agents and chemotherapy
Published: August 03, 2026
The Drug Update: Recent drug approvals, summer 2026 edition.
Journal: The Nurse practitioner
Published: July 31, 2026
In vitro evaluation of the activity of pairwise combinations of zoliflodacin, gepotidacin, and ciprofloxacin against Neisseria gonorrhoeae.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026
Uncomplicated Cure: The New Era of Gonorrhea Therapy With Oral Zoliflodacin.
Journal: American journal of therapeutics
Published: July 17, 2026
Extensively drug-resistant (XDR) Neisseria gonorrhoeae cured with ceftriaxone 2 g intravenous monotherapy in Croatia, March 2026.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: May 29, 2026
Zoliflodacin for Urogenital Gonorrhea Infections.
Journal: The Annals of pharmacotherapy
Published: May 28, 2026
Antimicrobial resistance in Neisseria gonorrhoeae isolates at the Bangrak STIs Center, Bangkok, Thailand and WGS of antimicrobial-resistant isolates, 2018-23.
Journal: The Journal of antimicrobial chemotherapy
Published: May 21, 2026
Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrB D429N in Neisseria gonorrhoeae.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
Some Newer Antibiotics Active Against Helicobacter pylori and Anaerobic Bacteria and the Potential Benefits of Their Wider Availability in More Countries: A Narrative Review.
Journal: Antibiotics (Basel, Switzerland)
Published: May 03, 2026
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea.
Journal: The Annals of pharmacotherapy
Published: April 11, 2026
Last Updated: 09/26/2026